Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,532 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Jim Cramer says he cringes at owning AT&T or Verizon as Bernstein flags Starlink competition risk, signaling a potent...
Ally Financial is off to a challenging start in 2026, with shares down as inflation and tariff risks bite auto lendin...
BitFuFu reports 2025 results showing a shift toward cloud mining and a swing into loss as energy costs rise and Bitco...
A new CoinGecko analysis finds Bitcoin prices tend to post larger one-day gains when purchased on US holidays versus ...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...
Bitcoin remains range-bound near the $59K area as buyers defend the $58K-$60K zone, but a decisive move higher is not...
New data shows ULTY's steep cost, via a 1.24% expense ratio, quietly chewing into returns even as distributions persi...
Jim Cramer declares Broadcom undervalued after a solid earnings quarter with AI revenue accelerating; investors weigh...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
Investors often wrestle with where to place bets: a volatile crypto project or a disruptive nuclear-tech equity. This...
In a volatile session, AT&T tumbled after a Supreme Court ruling favored the FCC on a data-privacy case, while major ...